These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 10097982)

  • 1. [Therapy indications in positive Borrelia titer].
    Graninger W
    Internist (Berl); 1999 Feb; 40(2):216. PubMed ID: 10097982
    [No Abstract]   [Full Text] [Related]  

  • 2. Cross immunity among types of Borrelia burgdorferi.
    Wienecke R; Neubert U; Volkenandt M
    Lancet; 1993 Aug; 342(8868):435. PubMed ID: 8101930
    [No Abstract]   [Full Text] [Related]  

  • 3. Clinical relevance of different IgG and IgM serum antibody responses to Borrelia burgdorferi after antibiotic therapy for erythema migrans: long-term follow-up study of 113 patients.
    Glatz M; Golestani M; Kerl H; Müllegger RR
    Arch Dermatol; 2006 Jul; 142(7):862-8. PubMed ID: 16847202
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Erythema migrans and serodiagnosis by enzyme immunoassay and immunoblot with three borrelia species.
    Stanek G; Breier F; Menzinger G; Schaar B; Hafner M; Partsch H
    Wien Klin Wochenschr; 1999 Dec; 111(22-23):951-6. PubMed ID: 10666807
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of immunosuppression on erythema migrans. A retrospective study of clinical presentation, response to treatment and production of Borrelia antibodies in 33 patients.
    Fürst B; Glatz M; Kerl H; Müllegger RR
    Clin Exp Dermatol; 2006 Jul; 31(4):509-14. PubMed ID: 16716151
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibody responses to borrelia IR(6) peptide variants and the C6 peptide in Swedish patients with erythema migrans.
    Tjernberg I; Sillanpää H; Seppälä I; Eliasson I; Forsberg P; Lahdenne P
    Int J Med Microbiol; 2009 Aug; 299(6):439-46. PubMed ID: 19138558
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A case from practice (306). Erythema (chronicum) migrans (stage I of Lyme borreliosis].
    Tschudi M
    Schweiz Rundsch Med Prax; 1994 Sep; 83(39):1091-2. PubMed ID: 7939077
    [No Abstract]   [Full Text] [Related]  

  • 8. [Reinfection with Borrelia burgdorferi in an immunocompetent patient].
    Hassler D; Maiwald M
    Dtsch Med Wochenschr; 1994 Mar; 119(10):338-42. PubMed ID: 8125037
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Determination of antibodies against Borrelia burgdorferi in patients with morphea, lichen sclerosus et atrophicus and erythema chronicum migrans].
    Pinazo Canales I; Betlloch Mas I; Mestre Bauza F; Salva Armengod F; Parras Vázquez F; Alomar Cardell J
    Rev Clin Esp; 1990 Apr; 186(7):320-3. PubMed ID: 2392594
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment failure in erythema migrans--a review.
    Weber K
    Infection; 1996; 24(1):73-5. PubMed ID: 8852475
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Butterfly rash in a young boy: a quiz.
    Benedix F; Geyer A; Röcken M; Biedermann T
    Acta Derm Venereol; 2010; 90(1):109-11. PubMed ID: 20107747
    [No Abstract]   [Full Text] [Related]  

  • 12. Erythema chronicum migrans in Suzhou, China.
    Song F
    Arch Dermatol; 1993 Jun; 129(6):793-4. PubMed ID: 8507094
    [No Abstract]   [Full Text] [Related]  

  • 13. Changes in Borrelia burgdorferi-specific serum IgG antibody levels in patients treated for acrodermatitis chronica atrophicans.
    Olsson I; Asbrink E; von Stedingk M; von Stedingk LV
    Acta Derm Venereol; 1994 Nov; 74(6):424-8. PubMed ID: 7701871
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of immunofluorescence test (IFT) and immuno (western) blot (WB) test in patients with erythema migrans.
    Ruzić-Sabljić E; Maraspin V; Cimperman J; Lotric-Furlan S; Strle F
    Wien Klin Wochenschr; 2002 Jul; 114(13-14):586-90. PubMed ID: 12422606
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serologic cross-reactivity of antibodies against Borrelia theileri, Borrelia burgdorferi, and Borrelia coriaceae in cattle.
    Rogers AB; Smith RD; Kakoma I
    Am J Vet Res; 1999 Jun; 60(6):694-7. PubMed ID: 10376894
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunoblot analysis of the seroreactivity to recombinant Borrelia burgdorferi sensu lato antigens, including VlsE, in the long-term course of treated patients with erythema migrans.
    Glatz M; Fingerle V; Wilske B; Ambros-Rudolph C; Kerl H; Müllegger RR
    Dermatology; 2008; 216(2):93-103. PubMed ID: 18216470
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Azithromycin versus doxycycline for treatment of erythema migrans: clinical and microbiological findings.
    Strle F; Preac-Mursic V; Cimperman J; Ruzic E; Maraspin V; Jereb M
    Infection; 1993; 21(2):83-8. PubMed ID: 8387966
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Anti-Borrelia burgdorferi antibodies in chronic erythema migrans, benign lymphadenosis cutis, scleroderma and scleroatrophic lichen].
    Afa G; Caprilli F; Crescimbeni E; Morrone A; Prignano G; Fazio M
    G Ital Dermatol Venereol; 1990 Sep; 125(9):369-73. PubMed ID: 2079346
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of antibody titers against borrelial strains isolated in Japan by the microcapsule agglutination test for serological studies of early Lyme disease.
    Arimitsu Y; Seki M; Nakao M; Miyamoto K
    Microbiol Immunol; 1994; 38(4):269-72. PubMed ID: 7935044
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and laboratory evaluation of a new recombinant ELISA for the serodiagnosis of Lyme disease.
    Hunfeld KP; Ernst M; Zachary P; Jaulhac B; Sonneborn HH; Brade V
    Wien Klin Wochenschr; 2002 Jul; 114(13-14):580-5. PubMed ID: 12422605
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.